688177.SHG Bio-Thera Solutions Ltd

Healthcare Biotechnology Shanghai Stock Exchange
17.75 CNY
Close of Nov 5, 2026
15.57 27.10
Market cap
CNY 7.35B
P/E
-
P/B
159.80x
ROE
-1,033.9%
Dividend yield
0.28%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 688177.SHG undervalued?

Graham number

The Graham number of Bio-Thera Solutions Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bio-Thera Solutions Ltd fundamental analysis

No fundamental analysis for Bio-Thera Solutions Ltd yet.

Bio-Thera Solutions Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bio-Thera Solutions Ltd

Bio-Thera Solutions, Ltd., a biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally. It offers QLETLI for the treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, Crohn's disease, and uveitis; POBEVCY to treat patients with metastatic colorectal cancer, non-squamous non-small cell lung cancer, recurrent gliob…

Full company profile